Internal Medicine, Endocrinology, Diabetes, & Metabolism · Flint, MI
NPI
1003921610
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5040 Villa Linde Pkwy
Flint, MI, 48532
Phone (810) 230-0788
Groups this clinician bills Medicare through
Medicare paid, 2024
$120K
2,519 services
Medicare patients, 2024
449
Average age 71
Drug cost, 2024
$4.7M
8,648 prescriptions
Company payments, 2025
$2,312
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad Bakleh was code 99214 (office e&m - established), 519 times for 293 patients. In total Muhammad Bakleh billed 2,519 services in 28 codes, and Medicare paid $120K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 519 | 293 | $91.67 | $48K |
| 99231 Hospital E&M - Subsequent | Facility | 361 | 72 | $40.38 | $15K |
| 99213 Office E&M - Established | Office | 311 | 204 | $68.22 | $21K |
| 83037 Blood Count | Office | 261 | 182 | $9.39 | $2,450 |
| 82947 Clinical Chemistry | Office | 244 | 160 | $3.82 | $932 |
| 95251 Test - Miscellaneous | Office | 212 | 107 | $26.78 | $5,676 |
| 83036 Blood Count | Office | 156 | 136 | $9.47 | $1,478 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 125 | 119 | $13.48 | $1,685 |
| 99232 Hospital E&M - Subsequent | Facility | 89 | 70 | $62.69 | $5,579 |
| 76536 Ultrasound - Nonspecific | Office | 41 | 37 | $74.67 | $3,062 |
| 95250 Test - Miscellaneous | Office | 39 | 36 | $105.71 | $4,123 |
| 99204 Office E&M - New | Office | 34 | 34 | $125.88 | $4,280 |
| 99215 Office E&M - Established | Office | 25 | 23 | $137.60 | $3,440 |
| 99406 Behavioral Health Services | Office | 19 | 11 | $15.06 | $286 |
| 96372 Injection Administration | Office | 18 | 16 | $9.62 | $173 |
By year: 2022 $125K for 2,935 services; 2023 $121K for 2,819 services; 2024 $120K for 2,519 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83037 Blood Count | 261 | 182 | $9.39 | $2,450 |
| 82947 Clinical Chemistry | 244 | 160 | $3.82 | $932 |
| 83036 Blood Count | 156 | 136 | $9.47 | $1,478 |
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad Bakleh prescribed most often to Medicare patients was Levothyroxine Sodium, with 928 prescriptions and refills. In total Muhammad Bakleh wrote 8,648 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 928 | 2,445 | 279 | $11K |
| Metformin Hcl Er Metformin Hcl | 555 | 1,371 | 180 | $5,254 |
| Jardiance Empagliflozin | 492 | 1,112 | 145 | $622K |
| Metformin Hcl Generic | 478 | 1,241 | 165 | $4,775 |
| Januvia Sitagliptin Phosphate | 440 | 892 | 112 | $433K |
| Trulicity Dulaglutide | 389 | 700 | 100 | $669K |
| Ozempic Semaglutide | 385 | 657 | 93 | $613K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 354 | 962 | 144 | $73K |
| Pioglitazone Hcl Generic | 276 | 772 | 98 | $6,079 |
| Mounjaro Tirzepatide | 265 | 445 | 76 | $467K |
| Glimepiride Generic | 223 | 561 | 64 | $1,875 |
| Novolog Flexpen Insulin Aspart | 191 | 347 | 79 | $44K |
| Farxiga Dapagliflozin Propanediol | 191 | 399 | 58 | $210K |
| Humalog Kwikpen U-100 Insulin Lispro | 182 | 460 | 82 | $79K |
| Amlodipine Besylate Generic | 173 | 395 | 55 | $1,677 |
Brand drugs: 4,621 claims; generic drugs: 3,445 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad Bakleh $2,312 ($2,312 in general payments such as food, travel and fees) from 26 companies. The largest payer was Amgen Inc. with $293.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 23 | $293 |
| Beta Bionics, Inc. BBNX | 18 | $273 |
| Corcept Therapeutics CORT | 17 | $252 |
| Novo Nordisk Inc NVO | 9 | $192 |
| Xeris Pharmaceuticals, Inc. | 8 | $158 |
| Radius Health, Inc. | 7 | $143 |
| Amneal Pharmaceuticals LLC AMRX | 5 | $106 |
| Ascendis Pharma Endocrinology Inc ASND | 5 | $101 |
| Abbvie Inc. ABBV | 5 | $88.37 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $88.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.